Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6577266 | 0.86 | SIGMAR1 (0.53) | KMT2AKDM4ESIGMAR1L3MBTL1CYP3A4 | |
| SCHEMBL2206046 | 0.79 | SIGMAR1 (0.59) | KMT2ASIGMAR1L3MBTL1OPRM1CYP3A4 | |
| SCHEMBL4123527 | 0.78 | SIGMAR1 (0.58) | KMT2ASIGMAR1L3MBTL1OPRM1CYP3A4 | |
| SCHEMBL6579261 | 0.77 | KMT2A (0.60) | KMT2AKDM4ESIGMAR1OPRM1CYP3A4 | |
| SCHEMBL6576890 | 0.77 | KMT2A (0.47) | KMT2AKDM4EL3MBTL1OPRM1CYP3A4 | |
| SCHEMBL7012242 | 0.76 | LMNA (0.67) | KMT2AKDM4EL3MBTL1OPRM1CYP3A4 | |
| SCHEMBL485328 | 0.75 | SIGMAR1 (0.55) | KMT2AKDM4ESIGMAR1L3MBTL1CYP3A4 | |
| SCHEMBL13398822 | 0.74 | SIGMAR1 (0.54) | KMT2AKDM4ESIGMAR1L3MBTL1CYP3A4 | |
| SCHEMBL6042898 | 0.74 | KMT2A (0.82) | KMT2AKDM4EOPRM1OPRL1ALDH1A1 | |
| SCHEMBL9228863 | 0.73 | SIGMAR1 (0.53) | KMT2ASIGMAR1L3MBTL1OPRM1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1199971-C | Quaternary ammonium compounds as tachykinin antagonists | PFIZER LTD (US) | 2005-05-04 | — | — | CN | disclosed |
| EP-0994876-B1 | QUATERNARY AMMONIUM COMPOUNDS AS TACHYKININ ANTAGONISTS | PFIZER LTD (GB) | 2004-09-08 | — | — | EP | disclosed |
| US-6380396-B1 | CHEMICAL INTERMEDIATES FOR ANTIINFLAMMATORY AGENTS | PFIZER INC. | 2002-04-30 | — | — | US | disclosed |
| US-6207678-B1 | USED FOR TREATING INFLAMMATORY DISEASE SUCH AS ARTHRITIS, PSORIASIS, ASTHMA OR INFLAMMATORY BOWEL DISEASE, CENTRAL NERVOUS SYSTEM DISORDER SUCH AS ANXIETY, DEPRESSION, DEMENTIA OR PSYCHOSIS, GASTROINTESTINAL DISORDERS | PFIZER INC | 2001-03-27 | — | — | US | disclosed |
| CN-1260795-A | quaternary ammonium compounds as tachykinin antagonists | PFIZER LTD (US) | 2000-07-19 | — | — | CN | disclosed |
| EP-0994876-A1 | QUATERNARY AMMONIUM COMPOUNDS AS TACHYKININ ANTAGONISTS | Pfizer Limited (GB) | 2000-04-26 | — | — | EP | disclosed |
| WO-1998057972-A1 | QUATERNARY AMMONIUM COMPOUNDS AS TACHYKININ ANTAGONISTS | PFIZER LIMITED (GB) | 1998-12-23 | — | — | WO | disclosed |